Please assess the completion status of the following clinical trial:

Trial Title: The Effect of Perioperative Intravenous Lidocaine Infusion on Opioid Consumption After Lumbar Spine Surgery

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patient undergoing one- or two-level posterior lumbar fusion with or without decompression at University of Vermont Medical Center~* 18-75 years of age~* Signed consent form~Exclusion Criteria:~* Allergy to lidocaine~* Contraindication to lidocaine, such as substantial hepatic impairment (alanine aminotransferase or aspartate transaminase more than twice normal), renal impairment (serum creatinine \>2 mg/dl)~* Seizures or a history of seizure disorder~* Congestive heart failure~* Arrythmias~* Chronic opioid use \>45 mg morphine equivalent per day~* Trauma patients~* Inter-body fusions~* Severe psychiatric comorbidities~* Planned epidural anesthesia or analgesia

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- Intravenous Lidocaine Infusion (Type: EXPERIMENTAL): Patients will be randomly assigned to receive 1 mg/kg lidocaine bolus and intraoperative infusion of 2 mg/min.
- Placebo Infusion (Type: PLACEBO_COMPARATOR): Patients will be randomly assigned to receive a 1mg/kg bolus of water with 5% dextrose and an intraoperative infusion of 2mg/min. of water with 5% dextrose.

Based on this trial design, predict the completion outcome and termination type (if applicable).